Glaukos Corporation

Glaukos is a leading ophthalmic medical technology and pharmaceutical company formed in 1998. Our mission at Glaukos is to truly transform vision by pioneering novel, dropless platforms that can meaningfully advance the standard of care and improve outcomes for patients suffering from sight-threatening chronic eye diseases. Our mantra “We’ll go First” embodies our commitment and determination to take chances, push the limits of scient, and disrupt the legacy treatment paradigms in our three key targeted disease patient populations: glaucoma, corneal disorders, and retinal diseases.